VEQTOR

+ business areaBioPharma R&D+Services

+ company logotype
+ annual revenue

2023 – 436,600 PLN
2024 – 1,700,000 PLN

VEQTOR serves the unmet needs and commercialization challenges of the Life Sciences Industry to develop life-saving therapies. Our services ensure manufacturing is safe and designed as intended.

We’re committed to reducing time, cost, waste, and redundancy without impact to quality and compliance. Our centers of excellence are quality by design, risk management, Kneat Gx paperless validation for accelerated project execution, all supported by our ISO9001 Quality Management Systems.